<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03149783</url>
  </required_header>
  <id_info>
    <org_study_id>16-1078</org_study_id>
    <nct_id>NCT03149783</nct_id>
  </id_info>
  <brief_title>Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores</brief_title>
  <acronym>TAP RCT</acronym>
  <official_title>A Randomized Controlled Trial to Determine if Pre- and Post- Operative Regional Pain Control (Transversus Abdominis Plane Block) With Ropivacaine Versus Placebo Leads to Lower Anesthetic and Narcotic Dosing, and Alters Pain Scores</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial to determine if pre- and post- operative regional pain control
      (transversus abdominis plane block) with ropivacaine versus placebo leads to lower anesthetic
      and narcotic dosing, and alters pain scores.

      This study plans to learn more about regional anesthesia and pain control during abdominal
      surgery. The study will gather data about the effectiveness of continuous catheter infusion
      of local anesthetic after an abdominal operation. Outcomes include pain scores, IV pain
      medicine requirements, and delirium.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 13, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Double Blind Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>&quot;Study drug&quot; label of drug</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>Days 0-7 following the operation</time_frame>
    <description>Pain scores from the visual analog scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of anesthetic</measure>
    <time_frame>During the operation</time_frame>
    <description>MAC of inhalational agent, or total amount of IV anesthetic used during the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of narcotic administered postoperatively</measure>
    <time_frame>Days 0-7 postop</time_frame>
    <description>Amount of morphine equivalents per day measured after the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Delirium</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have bilateral TAP catheters placed along with continuous infusion of ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will have bilateral TAP catheters placed along with continuous infusion of placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine HCL</intervention_name>
    <description>Ropivacaine injected after placement of catheters, then infused during the operation</description>
    <arm_group_label>Ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;=50 years.

          -  Subjects will be undergoing an elective intra-abdominal or abdominal wall operation,
             including pelvic operations. Surgery specialties included are general surgery,
             surgical oncology, urology, gynecology, plastic surgery.

        Exclusion Criteria:

          -  Subjects with a history of dementia or aphasia, as visual analog scale and confusion
             assessment will be unreliable.

          -  Patients with an epidural or spinal catheter block.

          -  Patients who do not speak English so that a language barrier is not confused with VAS
             scoring or confusion.

          -  Patients who are abusing alcohol defined by a high AUDIT score (&gt;8) will be excluded.

          -  History of bipolar disorder or a psychotic disorder (such as a psychotic major
             depression, schizophrenia, schizoaffective disorder, or psychosis in Alzheimer's
             disease or other dementia).

          -  Patients with a documented allergy to ropivacaine or other sodium channel blockers.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Denver Veterans Affairs Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Robinson, MD</last_name>
      <phone>303-399-8020</phone>
      <phone_ext>2952</phone_ext>
      <email>thomas.robinson@ucdenver.edu</email>
    </contact>
    <contact_backup>
      <last_name>Douglas Overbey, MD</last_name>
      <phone>573-225-7728</phone>
      <email>douglas.overbey@ucdenver.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas N Robinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No sharing</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

